beta-L-Fucp-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Term ID

CHEBI:146620

Synonyms

(2S,3S,4R,5S,6S)-2-methyl-6-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
6-deoxy-beta-L-galacto-hexopyranosyl-(1->6)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
6-deoxy-beta-L-galactopyranosyl-(1->6)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
beta-L-fucopyranosyl-(1->6)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
Fuc(b1-6)Gal(b1-4)Glc

Definition

A trisaccharide consisting of β-L-fucopyranose, β-D-galactopyranose and D-glucopyranose residues joined in sequence by (1→6) and (1→4) glycosidic bonds.

References

glygen:G02145PB
glytoucan:G02145PB
kegg.glycan:G09216

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-L-Fucp-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Phenotype where environments contain beta-L-Fucp-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Phenotype modified by environments containing beta-L-Fucp-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Phenotype affecting beta-L-Fucp-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Human Disease Model